<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the prevalence and factors associated with diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in the Australian population and to estimate the time difference between disease <z:hpo ids='HP_0003674'>onset</z:hpo> and clinical diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The Australian <z:mp ids='MP_0002055'>Diabetes</z:mp>, <z:hpo ids='HP_0001513'>Obesity</z:hpo> and Lifestyle study (AusDiab) included 11,247 adults aged &gt; or =25 years in 42 randomly selected areas of Australia </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000488'>Retinopathy</z:hpo> was assessed in participants identified as having <z:mp ids='MP_0002055'>diabetes</z:mp> (based on self-report and oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test), impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and in a random sample with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="3" pm="."><plain>Data were available for 2,177 participants </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Overall, 15.3% of those with <z:mp ids='MP_0002055'>diabetes</z:mp> had <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> was 21.9% in those with known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (KDM) and 6.2% in those newly diagnosed (NDM) </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>) was 2.1% in those with KDM </plain></SENT>
<SENT sid="7" pm="."><plain>No cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> were found in those with NDM </plain></SENT>
<SENT sid="8" pm="."><plain>Untreated vision threatening <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (presence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> or macular <z:hpo ids='HP_0000969'>edema</z:hpo>) was present in 1.2% (n = 4) </plain></SENT>
<SENT sid="9" pm="."><plain>Factors associated with <z:hpo ids='HP_0000488'>retinopathy</z:hpo> were duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, HbA(1c), and systolic blood pressure </plain></SENT>
<SENT sid="10" pm="."><plain>Using linear extrapolation of the prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> with <z:mp ids='MP_0002055'>diabetes</z:mp> duration, the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> in this population was approximately the time of diagnosis </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: This is one of the first national studies of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in a developed country </plain></SENT>
<SENT sid="12" pm="."><plain>The prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> was similar to that in other population-based studies </plain></SENT>
<SENT sid="13" pm="."><plain>Vision threatening <z:hpo ids='HP_0000488'>retinopathy</z:hpo> was relatively rare; however, four untreated cases were identified </plain></SENT>
<SENT sid="14" pm="."><plain>Regular screening for diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and more aggressive management of modifiable risk factors could reduce the numbers of people who develop vision-threatening <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
</text></document>